{
    "2019-01-18": [
        [
            {
                "time": "2023-10-17",
                "original_text": "AbbVie's Imbruvica fails to meet main goal in pancreatic cancer study",
                "features": {
                    "keywords": [
                        "Imbruvica",
                        "pancreatic cancer",
                        "study failure"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "AbbVie's cancer drug fails to meet main goal in late-stage study",
                "features": {
                    "keywords": [
                        "cancer drug",
                        "late-stage",
                        "study failure"
                    ],
                    "sentiment_score": -0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICAÂ®) in Metastatic Pancreatic Cancer",
                "features": {
                    "keywords": [
                        "Phase 3",
                        "Ibrutinib",
                        "metastatic pancreatic cancer"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "These 3 Biotech Stocks Appear Poised To Beat Fourth-Quarter Forecasts",
                "features": {
                    "keywords": [
                        "biotech stocks",
                        "fourth-quarter",
                        "forecasts"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "Can AbbVie (ABBV) Keep the Earnings Surprise Streak Alive?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "earnings surprise",
                        "streak"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "AbbVie (ABBV) Reports Next Week: Wall Street Expects Earnings Growth",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "earnings growth",
                        "Wall Street"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "Pacira's Study on Exparel Label Expansion Meets Endpoints",
                "features": {
                    "keywords": [
                        "Pacira",
                        "Exparel",
                        "label expansion",
                        "meets endpoints"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "Are you a Tortoise or a Hare Investor?",
                "features": {
                    "keywords": [
                        "Tortoise",
                        "Hare",
                        "Investor"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "Zacks Market Edge Highlights: Occidental, Gilead, AbbVie, AT&T and Verizon",
                "features": {
                    "keywords": [
                        "Zacks Market Edge",
                        "Occidental",
                        "Gilead",
                        "AbbVie",
                        "AT&T",
                        "Verizon"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "energy",
                        "healthcare",
                        "telecommunications"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}